MedTrace Logo

Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery

NCT02793492 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-03-25

No results posted yet for this study

Summary

This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.

Conditions

  • Iliac Artery Stenosis

Interventions

DEVICE

Misago® RX Self-expanding Peripheral Stent

the Misago® RX Self-expanding Stent is a bare metal, nitinol stent

Sponsors & Collaborators

  • Terumo Medical Corporation

    lead INDUSTRY

Principal Investigators

  • John Rundback, MD · Holy Name Medical Center

  • Charis Sugden · Terumo Medical Corporation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-30
Primary Completion
2025-02-24
Completion
2026-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793492 on ClinicalTrials.gov